London Daily

Focus on the big picture.
Wednesday, Jul 23, 2025

Silicon Valley is coming for your gut biome

Silicon Valley is coming for your gut biome

Venture capitalists who have made fortunes investing in software and hardware are putting tens of millions of dollars into companies that make probiotic pills.
Cryptocurrency hasn’t worked out so well for tech investors. Neither has the metaverse so far. Self-driving cars have been slow to arrive, and social media doesn’t have the hyper-fast growth that it did a few years ago. 

So where can a savvy tech investor turn these days in search of the next big idea? Two words: dietary supplements.   

Some venture capitalists who have made fortunes investing in software and hardware are putting tens of millions of dollars into companies that make probiotic pills, capsules filled with plant extracts and other nutritional supplements as a potential new frontier. 

As a consumer product, supplements are associated more with the Kardashians or Joe Rogan than with Silicon Valley. The industry is infamous for its lack of regulation under a 1994 federal law that exempts supplements from most Food and Drug Administration oversight, and it has boomed in recent years despite questions about efficacy.

Now, venture capitalists are betting that advances in DNA sequencing and related techniques will usher in a new and more credible wave of supplements, focused especially on gut health. 

Roelof Botha, the managing partner of Sequoia Capital, one of the largest venture capital firms in the world, is among those buying in. He said there’s a “societal reawakening” about the complex biome of the human gut where hundreds of species of bacteria live. 

“Inadvertently, we entered this era where we had an adversarial stance between humans and the rest of nature,” he said. “We overused antibiotics. We overused soaps. And now we’re going back into balance.” 

Botha is best known in the tech industry for early bets on Instagram and YouTube, but he said he became interested in gut health after Sequoia invested in genetics testing companies such as 23andMe. That interest led Sequoia to invest in Pendulum, a San Francisco startup that’s selling probiotic supplements. 

He takes them himself. “There’s nothing like getting live microbes into your system,” he said. 

Sequoia has plenty of company. In 2021, venture capitalists invested $488 million in probiotic companies and other supplement startups worldwide, five times what they invested five years earlier, according to PitchBook, a research firm that tracks startup investments. The money last year went to 99 separate funding deals — a record high for activity, according to Pitchbook. 

The money includes investments from pharmaceutical and food giants, but also from Silicon Valley elite who don’t come from the world of biotech. 

Khosla Ventures, headed by a co-founder of Sun Microsystems, is also an investor in Pendulum. Y Combinator, a well-known tech incubator, has a stake in Persephone Biosciences, a startup researching potential cancer treatments involving gut microbes. Social Capital, another large venture capital firm, invests in a startup called ZBiotics that sells a probiotic drink as a hangover cure. 

It’s a welcome development for some startup founders. 

“Five years ago, the investors were health investors who had a background in health, or food investors who had a background in food,” said Sofia Elizondo, a co-founder of Brightseed, a San Francisco startup that’s developing gut health products. 

“And what we’re finding is a lot of crossover investor interest now, where a lot of capital shares the thesis that precise, molecular-level proactive health is the way of the future,” she said. 

There’s already been one cautionary tale about how a probiotic startup can go wrong. uBiome, a San Francisco startup that promised to give people insight into their microbiome based on tests of fecal matter, attracted tens of millions of dollars in investments including from the venture capital firms Andreessen Horowitz and Y Combinator. 

But last year, federal prosecutors said uBiome’s tests weren’t scientifically valid and they charged the founders, Zachary Apte and Jessica Richman, with fraud. The two were living in Germany as of last year and have not been extradited to face the charges, The Wall Street Journal reported. Their lawyers did not respond to requests for comment. 

Still, the episode hasn’t soured venture capitalists on the potential of “nutraceuticals,” which fit in with a certain strain of Silicon Valley self-improvement culture known as biohacking.

As a business, probiotics and other supplements have at least two advantages that venture capitalists typically look for. One is steady recurring revenue, which comes from people taking pills daily or food manufacturers using them as additives to control insulin, improve digestion or attempt weight-loss. 

The other is a lack of strict regulation. The ingredients must be generally regarded as safe and the manufacturers can’t market supplements as more effective than the research shows, but supplements don’t need to go through the same rigorous approval process as pharmaceuticals. 

Botha, from Sequoia Capital, said he believes genetics research has similar potential to microchips a generation ago, when microchip power was expected to double every two years under a principle called Moore’s Law. 

DNA sequencing has “progressed faster than Moore’s law,” he said. And that, he added, is what makes the sector a good target for Silicon Valley. “It’s about understanding biology as an information science.” 

Elisa Marroquín, an assistant professor of nutritional sciences at Texas Christian University, said that the science around the new wave of supplements is still new, but she said at least some tech startups seem to be on the right track. She said she doesn’t have a financial relationship with any startups, though she has spoken with them about obtaining samples for research.

“We’re still very early in the understanding of these bacterial species,” Marroquín said. She co-wrote a review of the science this year, and said future probiotic supplements have promise compared to supplements that have been available for decades. 

“I do believe they’re going to have stronger effects on our health than the current probiotics that are on the market,” she said. 

But part of the challenge for the new wave of supplements startups is to change the perception of their industry as unscientific or as a kind of Northern California witchcraft. 

Among certain scientists, “probiotics are definitely this voodoo,” said Colleen Cutcliffe, a co-founder of Pendulum and its CEO. She has a doctorate in biochemistry from Johns Hopkins University, and her two co-founders also have doctorates. 

“In fact, in the first eight years of our company, I didn’t let anyone use the p-word to discuss our product,” she said, referring to probiotics. “I said, ‘This is a microbiotic intervention.’”

Pendulum sells a few products so far, including a supplement with akkermansia muciniphila, a gut bacteria that it markets as a “next generation probiotic” linked to controlling diet-induced obesity. The bacteria is difficult to manufacture alive because it can die when it comes into contact with oxygen, Cutcliffe said, so Pendulum has built a proprietary process that keeps oxygen out. 

Cutcliffe said there are tens of thousands of gut bacteria strains still to be studied, with a $60 billion global probiotic industry waiting for new products — which is what has caught investors’ eyes. 

“What appealed to these folks was the idea of category creation, and an already existing huge market that hadn’t had any innovation in a long time,” she said.
Comments

Oh ya 3 year ago
Or you can just eat fermented foods and not buy there overpriced pills

Newsletter

Related Articles

0:00
0:00
Close
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
×